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BACKGROUND 
 
Chronic  Obstructive  Pulmonary  Disease  (COPD)  is  characterized by chronic 
airflow limitation and various  pathological changes in the lungs.  COPD also 
presents  with significant extra-pulmonary effects and is associated with various 
important co morbidities that may contribute to disease severity. 
 Chronic airflow limitation(CRL) is associated with an abnormal inflammatory 
response of the lung to noxious particles  or gases, particularly cigarette smoke. 
The main causes of morbidity and mortality among COPD patients are 
cardiovascular disease . Cardiovascular disease is the leading cause of death 
worldwide , and smoking is the significant modifiable risk factor related to CVD .  
Among COPD patients, Cardiovascular disease(CVD) is responsible for 
approximately 50% of all hospitalizations and 20% of all deaths . However studies 
have suggested that regardless of smoking status, age or sex, a COPD diagnosis 
increases the risk of cardiovascular morbidity and mortality by approximately 
about two fold . Left Ventricular Diastolic Dysfunction(LVDD)  is found to be a 
complication of COPD due to chronic hypoxia and as a consequence of 
inflammatory changes in the body.   Eventhough Right Ventricular dysfunction is 
well studied in COPD patients, the presence of Left ventricular diastolic 
dysfunction(LVDD) in COPD patients is associated with increase in disease 
severity and frequent hospital admission . 
 
Anthonisen et al. and Sin et al. have already assessed the association among 
COPD, CVD and increased serum concentrations of inflammatory markers like C- 
Reactive Protein (CRP) .  
 
Inflammation is considered to be one of the systemic manifestations of COPD and 
provides an alternative hypothesis to explain the relationship between airflow 
limitation and cardiovascular risk . The current study is undertaken to analyse the 
prevalence of LV diastolic dysfunction in COPD and its relation to disease 
severity. Also to check whether the elevated CRP correlates with the prevalence of 
LVDD and severity of COPD. 
 
 
 
AIMS & OBJECTIVES 
         To assess the prevalence of Left ventricular diastolic dysfunction (LVDD) in 
COPD patients. 
          To assess the relationship between COPD severity according to GOLD 
criteria and grading of  LVDD and its correlation with inflammatory marker                   
C-REACTIVE PROTEIN. 
METHODS 
Setting: Department Of General Medicine , Govt Rajaji Hospital, Madurai Medical 
College, Madurai. STUDY DESIGN: Prospective and observational study.This 
study will be conducted in 100 COPD patients. All patients are subjected to full 
medical history , basic blood investigations, CXR, SPIROMERETY, ECG, C- 
REACTIVE PROTIEN, ECHOCARDIOGRAPHY.They are classified into group 
1 & group 2 according to GOLD criteria  based on PFT.GROUP I - Mild & 
Moderate (GOLD CLASS 1&2)  and GROUP II - Severe & very severe (GOLD 
CLASS 3&4)  and study its associations with LVDD Grading based on  
echocardiography & its correlation with Serum  CRP. SOURCE OF 
DATA:COPD patients attending / admitted in Thoracic Medicine & General 
Medicine OPD/ Wards during the period of March 2018 to August 2018 at Govt 
Rajaji Hospital, Madurai .SAMPLE SIZE:100 COPD Patients.STUDY 
DURATION:  6 Months.INCLUSION CRITERIA :One Hundred patients 
diagnosed as COPD as per GOLD( GLOBAL INITIATIVE FOR CHRONIC 
OBSTRUCTIVE PULMONARY DISEASE) were included in the study 
population .EXCLUSION CRITERIA: Diabetes Mellitus, Systemic 
Hypertension, Obesity based on BMI, Other chronic lung disease like asthma ,ILD, 
PTB, Obstructive sleep apnea , Associated other known cardiac disease like CAD, 
Arrythmiyas, valvular or congenital Heart disease. METHOD OF 
COLLECTING DATA :COPD patients of varying age and sex were selected 
carefully using GOLD criteria. Their written consent was taken. The history was 
elicited. Age, height, weight were recorded. Thorough clinical examination were 
carried out.The performance of PFT were demonstrated. Patients were made to 
undergo pulmonary function tests using Medspiror, for 3 times at every 15 minutes 
interval and best of 3readings was taken. The Forced Vital Capacity (FVC), Forced 
Expiratory Volume at the end of one second (FEV1),FEV1/ FVC ratio & FEV1 
Predicted were recorded. Patient belonging all stages of COPD as per GOLD 
guidelines were included for the study. Then they were subjected to 
Echocardiography and blood investigations. DATA COLLECTION: Relevant 
History & Clinical Examination, Age, sex, Height, Weight, BMI, Basic blood 
investigations, C-REACTIVE PROTIEN, Pulmonary Function Test By 
Spirometry, Saturated Hb with o2 by Pulse oximeter, ECG, Chest Xray PA View, 
ECHOCARDIOGRAPHY. 
RESULTS 
100 COPD subjects admitted in the Govt Rajaji Hospital were study for left 
ventricular dysfunction during  March 2018 to August 2018. Age of the subjects 
varied from 18 to 65 years of age. Males were 78 , Females were 22. COPD 
severity based on GOLD class as Mild – 13, Moderate - 25, Severe – 49 and Very 
severe - 13patients in the study. Prevalence of LVDD dysfunction in COPD 
subjects was 61% of study population with Normal being 39% of study population 
with GROUP 1 & GROUP 2 being 39.5% and 74.5% respectively,which was 
statistically significant.C – Reactive protein was positive in  35% of COPD 
patients in the study group, with GROUP 1 & GROUP 2 being 10.5% and 50% 
respectively,which was statistically significant.C – Reactive protein was positive in 
26% Patients with grade 1 & 2 LVDD and 67% in Grade 3& 4 LVDD, which was 
statistically significant. There was also prolonged hospital stay in patients with 
grade 3 and 4 left ventricular diastolic dysfunction.  
Thus from the study, we came to know that as the COPD individuals progress in 
the airflow limitation from mild to moderate, severe & then to very severe COPD 
stages , they encounter higher prevalence of left ventricular diastolic dysfunction 
with correlation of inflammatory marker which remarkably affects severity of 
disease and the quality of life of COPD individuals  
Thus from the study, we came to know that as the COPD individuals progress in 
the airflow limitation from mild to moderate, severe & then to very severe COPD 
stages , they encounter higher prevalence of left ventricular diastolic dysfunction 
with correlation of inflammatory marker which remarkably affects severity of 
disease and the quality of life of COPD individuals. 
CONCLUSION 
COPD patients in their due course of the illness develop multiple systemic 
complications. LVDD is one among such systemic complications of COPD. As 
there is progressive airflow limitation, the severity of COPD progress which results 
in varied grades of  LVDD. In conclusion there is a high prevalence of LVDD in 
COPD patients which is associated with increased disease severity 
according to GOLD classification and with the presence high levels of 
inflammatory markers (CRP), and it is important to exclude decompensated heart 
failure during COPD exacerbation. Hence COPD patients should be regularly 
monitored for abnormal LVDD & managed accordingly to improve their quality of 
life. 
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